Artwork
iconShare
 
Manage episode 288623524 series 2902383
Content provided by Myriad Genetics. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Myriad Genetics or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Dr. Mike Gambla from Central Ohio Urology Group joins The Modern Urologist to talk about his experience with private equity acquisitions (PE) in the Urology space. The idea of potential culture disruptions and other pros and cons of PE acquisitions are discussed at length. Dr. Gambla offers his own insights to any independent practice considering an acquisition. The conversation changes to the role nurse navigators play in getting patients with advanced disease states better care through second and third line therapies. The need for analytics to improve patient outcomes and forecast practice needs are also discussed.

Send us a text

  continue reading

54 episodes